Actionable news
All posts from Actionable news
Actionable news in BSX: BOSTON SCIENTIFIC Corp,

Boston Scientific: RBC's Channel Checks Point To Upside Not Baked In Stock Price

Invest with Confidence. Are you a financial professional? Stay on top of your portfolio with Benzinga Pro's real-time newsfeed and alerts and never miss a headline again.
Don't miss the chance to try it FREE today.

The launches of Synergy and Watchman by Boston Scientific Corporation BSX 0.1% appear ahead of plan. RBC Capital Markets’ Glenn Novarro maintained an Outperform rating for the company, while raising the price target from $20 to $22.

Boston Scientific is a “multiyear growth story,” driven by its near-term product cycle, which is expected to result in incremental share gains in the CRM, structural heart, and...